title: Exposing the evil in the dark: the usefulness of delayed-phase FDG PET scan to enhance the detectability of tiny residual skull base osteosarcoma initially concealed by adjacent high physiological brain activity.
authors.affiliation: Department of Nuclear Medicine, Shin Kong Wu Ho-Su Hospital, Taipei, Taiwan.
authors.forename: Yen-Kung
authors.initials: YK
authors.lastname: Chen
authors.forename: Chia-Hung
authors.initials: CH
authors.lastname: Kao
authors.forename: Shung-Shung
authors.initials: SS
authors.lastname: Sun
authors.forename: Ji-An
authors.initials: JA
authors.lastname: Liang
authors.forename: Chih-Hsiu
authors.initials: CH
authors.lastname: Wang
authors.forename: Yu-Chin
authors.initials: YC
authors.lastname: Wu
authors.forename: Yu-Yi
authors.initials: YY
authors.lastname: Lin
authors.forename: Kuo-Yang
authors.initials: KY
authors.lastname: Yen
authors.forename: Te-Chun
authors.initials: TC
authors.lastname: Hsieh
mesh_terms: D001921:Brain / Q000000981:diagnostic imaging / Q000503:physiopathology*; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008297:Male; D008875:Middle Aged; D018365:Neoplasm, Residual; D012516:Osteosarcoma / Q000000981:diagnostic imaging* / Q000503:physiopathology*; D049268:Positron-Emission Tomography; D012680:Sensitivity and Specificity; D019292:Skull Base Neoplasms / Q000000981:diagnostic imaging* / Q000503:physiopathology*; D013997:Time Factors; D014057:Tomography, X-Ray Computed
chemical_list: D019788:Fluorodeoxyglucose F18